| GTO ID | GTC1004 |
| Trial ID | ChiCTR2200061539 |
| Disease | B-Cell Acute Lyphoblastic Leukemia |
| Therapy | CAR-T cell |
| Treatment | RD06-03 |
| Recruitment status | Recruiting |
| Title | Safety and efficacy of RD06-03 CAR T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Peking University Shenzhen Hospital |
| Cohort 1 | |||||||
|
|||||||